Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Malignant Lymphoma

  Free Subscription

Articles published in Oncol Rep

Retrieve available abstracts of 31 articles:
HTML format

Single Articles

    April 2021
  1. DUONG HQ, Than VT, Nguyen HT, Nguyen PT, et al
    Anaplastic lymphoma kinase inhibitor NVPTAE684 suppresses the proliferation of human pancreatic adenocarcinoma cells.
    Oncol Rep. 2021;45:1-11.
    PubMed     Abstract available

    January 2021
  2. XIE S, Fan W, Yang C, Lei W, et al
    Beclin1armed oncolytic Vaccinia virus enhances the therapeutic efficacy of RCHOP against lymphoma in vitro and in vivo.
    Oncol Rep. 2021 Jan 19. doi: 10.3892/or.2021.7942.
    PubMed     Abstract available

    December 2020
  3. FU J, Lou X, Wan S, Zhao X, et al
    microRNA196a3p inhibits cell proliferation and promotes cell apoptosis by targeting ADP ribosylation factor 4 in diffuse large Bcell lymphoma.
    Oncol Rep. 2020 Dec 16. doi: 10.3892/or.2020.7901.
    PubMed     Abstract available

  4. TAO HF, Shen JX, Hou ZW, Chen SY, et al
    lncRNA FOXP4AS1 predicts poor prognosis and accelerates the progression of mantle cell lymphoma through the miR4235p/NACC1 pathway.
    Oncol Rep. 2020 Dec 11. doi: 10.3892/or.2020.7897.
    PubMed     Abstract available

    November 2020
  5. GIBBS JD, Ma S, Kim A, Seminario-Vidal L, et al
    Utility of flow cytometry and gene rearrangement analysis in tissue and blood of patients with suspected cutaneous Tcell lymphoma.
    Oncol Rep. 2020 Nov 23. doi: 10.3892/or.2020.7865.
    PubMed     Abstract available

  6. WANG L, Wang W
    Safety and efficacy of anaplastic lymphoma kinase tyrosine kinase inhibitors in nonsmall cell lung cancer (Review).
    Oncol Rep. 2020 Nov 13. doi: 10.3892/or.2020.7851.
    PubMed     Abstract available

  7. ZHANG L, Zhou S, Zhou T, Yuan K, et al
    S100A8 promotes chemoresistance via augmenting autophagy in Bcell lymphoma cells.
    Oncol Rep. 2020 Nov 9. doi: 10.3892/or.2020.7841.
    PubMed     Abstract available

  8. ZHANG R, Zhu H, Yuan Y, Wang Y, et al
    SPAG6 promotes cell proliferation and inhibits apoptosis through the PTEN/PI3K/AKT pathway in Burkitt lymphoma.
    Oncol Rep. 2020;44:2021-2030.
    PubMed     Abstract available

    October 2020
  9. KIM J, Kim JN, Park I, Sivtseva S, et al
    Dracocephalum palmatum Stephan extract induces caspase and mitochondriadependent apoptosis via Myc inhibition in diffuse large B cell lymphoma.
    Oncol Rep. 2020 Oct 8. doi: 10.3892/or.2020.7797.
    PubMed     Abstract available

    August 2020
  10. WU S, Zhang X, Dong M, Yang Z, et al
    sATPbinding cassette subfamily G member 2 enhances the multidrug resistance properties of human nasal natural killer/T cell lymphoma side population cells.
    Oncol Rep. 2020 Aug 10. doi: 10.3892/or.2020.7722.
    PubMed     Abstract available

    January 2020
  11. CHEN W, Li W, Bai B, Wei H, et al
    Identification of anaplastic lymphoma kinase fusions in clear cell renal cell carcinoma.
    Oncol Rep. 2020 Jan 14. doi: 10.3892/or.2020.7462.
    PubMed     Abstract available

  12. LI C, Xu Y, Xin P, Zheng Y, et al
    Role and mechanism of PTEN in Burkitt's lymphoma.
    Oncol Rep. 2020 Jan 9. doi: 10.3892/or.2020.7457.
    PubMed     Abstract available

    August 2019
  13. WANG X, Tan Y, Huang Z, Huang N, et al
    Disrupting myddosome assembly in diffuse large Bcell lymphoma cells using the MYD88 dimerization inhibitor ST2825.
    Oncol Rep. 2019 Aug 19. doi: 10.3892/or.2019.7282.
    PubMed     Abstract available

  14. MAZZOCCOLI L, Robaina MC, Bacchi CE, Soares Lima SC, et al
    miR29 promoter and enhancer methylation identified by pyrosequencing in Burkitt lymhoma cells: Interplay between MYC and miR29 regulation.
    Oncol Rep. 2019;42:775-784.
    PubMed     Abstract available

    July 2019
  15. DOMINGUEZ-GOMEZ G, Cortez-Pedroza D, Chavez-Blanco A, Taja-Chayeb L, et al
    Growth inhibition and transcriptional effects of ribavirin in lymphoma.
    Oncol Rep. 2019 Jul 17. doi: 10.3892/or.2019.7240.
    PubMed     Abstract available

    June 2019
  16. ZHANG R, Deng Q, Jiang YY, Zhu HB, et al
    Effect and changes in PD1 expression of CD19 CART cells from T cells highly expressing PD1 combined with reduceddose PD1 inhibitor.
    Oncol Rep. 2019;41:3455-3463.
    PubMed     Abstract available

    May 2019
  17. SU H, Chang J, Xu M, Sun R, et al
    CDK6 overexpression resulted from microRNA320d downregulation promotes cell proliferation in diffuse large Bcell lymphoma.
    Oncol Rep. 2019 May 2. doi: 10.3892/or.2019.7144.
    PubMed     Abstract available

    April 2019
  18. LIU J, Liang L, Li D, Nong L, et al
    JAK3/STAT3 oncogenic pathway and PRDM1 expression stratify clinicopathologic features of extranodal NK/Tcell lymphoma, nasal type.
    Oncol Rep. 2019 Apr 12. doi: 10.3892/or.2019.7112.
    PubMed     Abstract available

    November 2018
  19. YAN W, Li SX, Wei M, Gao H, et al
    Identification of MMP9 as a novel key gene in mantle cell lymphoma based on bioinformatic analysis and design of cyclic peptides as MMP9 inhibitors based on molecular docking.
    Oncol Rep. 2018;40:2515-2524.
    PubMed     Abstract available

    October 2018
  20. HUANG Y, Zou Y, Lin L, Ma X, et al
    miR101 regulates the cell proliferation and apoptosis in diffuse large Bcell lymphoma by targeting MEK1 via regulation of the ERK/MAPK signaling pathway.
    Oncol Rep. 2018 Oct 24. doi: 10.3892/or.2018.6821.
    PubMed     Abstract available

  21. ZHUANG L, Lai J, Chen K, Ding T, et al
    Intraocular involvement is associated with a high risk of disease relapse in primary central nervous system lymphoma.
    Oncol Rep. 2018 Oct 11. doi: 10.3892/or.2018.6781.
    PubMed     Abstract available

  22. KALAVSKA K, Kucerova L, Schmidtova S, Toro L, et al
    Lymphoma transformation of tumor infiltrating lymphocytes observed in testicular patientderived xenograft models.
    Oncol Rep. 2018 Oct 5. doi: 10.3892/or.2018.6769.
    PubMed     Abstract available

    September 2018
  23. NIU X, Ji H, Wang Y, Hu S, et al
    Systemic immune response associated with radiation therapy in Bcell nonHodgkin's lymphoma of Waldeyer's ring.
    Oncol Rep. 2018 Sep 28. doi: 10.3892/or.2018.6748.
    PubMed     Abstract available

    January 2018
  24. SONG YH, Zhong MZ, Chai Q, Gong KY, et al
    The role of aldehyde dehydrogenase 1A1 in B-cell non-Hodgkin's lymphoma.
    Oncol Rep. 2018 Jan 18. doi: 10.3892/or.2018.6220.
    PubMed     Abstract available

    December 2017
  25. KARAM L, Houshaymi B, Abdel-Samad R, Jaafar M, et al
    Antitumor activity of the synthetic retinoid ST1926 on primary effusion lymphoma in vitro and in vivo models.
    Oncol Rep. 2017 Dec 5. doi: 10.3892/or.2017.6137.
    PubMed     Abstract available

    September 2017
  26. ISHIKAWA C, Mori N
    In vitro and in vivo anti-primary effusion lymphoma activities of fucoidan extracted from Cladosiphon okamuranus Tokida.
    Oncol Rep. 2017 Sep 20. doi: 10.3892/or.2017.5978.
    PubMed     Abstract available

  27. LI XY, Li Y, Zhang L, Liu X, et al
    The antitumor effects of arsenic trioxide in mantle cell lymphoma via targeting Wnt/betacatenin pathway and DNA methyltransferase-1.
    Oncol Rep. 2017 Sep 7. doi: 10.3892/or.2017.5945.
    PubMed     Abstract available

    July 2017
  28. GAO HY, Wu B, Yan W, Gong ZM, et al
    Microarray expression profiles of long non-coding RNAs in germinal center-like diffuse large B-cell lymphoma.
    Oncol Rep. 2017 Jul 14. doi: 10.3892/or.2017.5821.
    PubMed     Abstract available

    June 2017
  29. ZHOU X, Zhang Y, Li Y, Xu Y, et al
    Klotho suppresses tumor progression via inhibiting IGF-1R signaling in Tcell lymphoma.
    Oncol Rep. 2017 Jun 22. doi: 10.3892/or.2017.5744.
    PubMed     Abstract available

    May 2017
  30. DOU A, Wang Z, Zhang N, Liu J, et al
    Loss of Reelin suppresses cell survival and mobility in non-Hodgkin lymphoma.
    Oncol Rep. 2017 May 4. doi: 10.3892/or.2017.5626.
    PubMed     Abstract available

    February 2017
  31. OKUYAMA H, Tominaga A, Fukuoka S, Taguchi T, et al
    Spirulina lipopolysaccharides inhibit tumor growth in a Toll-like receptor 4-dependent manner by altering the cytokine milieu from interleukin-17/interleukin-23 to interferon-gamma.
    Oncol Rep. 2017;37:684-694.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.